How Your Body Processes an Experimental Drug
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tracks how a new experimental drug (HRS-1780) moves through and leaves your body. Researchers will give you a single dose and measure where it goes and how it's eliminated, which helps them understand if it's safe for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male between 18 and 45 years old
- You weigh at least 50 kg (about 110 lbs) and have a BMI between 19 and 26
- You have no serious health conditions (heart, liver, kidney, mental health, infections, or recent surgery)
- You are willing not to father children or donate sperm for 3 months and will use birth control
- You have not taken other experimental drugs in the past 3 months and won't take other trials during this study
- You can stop all medicines (except vitamins and occasional pain relievers), alcohol, smoking, and herbal supplements for the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called HRS-2183 in healthy volunteers to see how safe it is and how the body processes it after a single dose and after multiple doses. It's a first step in studying this potential medicine.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study looks at how a single dose of an investigational drug called HRS-1893 is processed and removed from the body in healthy men. You'll stay at the clinic and provide blood and urine samples for several days.
This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.